Richard L. Schilsky Cancer and Leukemia Group B
Achievement Award

The Alliance for Clinical Trials in Oncology Foundation invites nominations for the Richard L. Schilsky Cancer and Leukemia Group B Achievement Award each year.

The RLS CALGB Achievement Award was established in 2010 to recognize the 15-year tenure of Dr. Schilsky as Group Chair of Cancer and Leukemia Group B (CALGB). The award acknowledges the significant contributions of an individual to cooperative group research. As an organization, it is vital for the Alliance to identify and honor the talented people responsible for its success. This award honors individuals who have shaped Alliance into a stronger organization, either through past leadership or other contributions. The award was made possible through generous donations from Alliance members and industry supporters. 

All Alliance members are invited to submit nominations for this award. As the award is intended to recognize “unsung heroes,” we kindly ask that you refrain from nominating colleagues currently serving in major leadership roles (e.g., Disease or Modality Committee Chairs, Program Directors). The award is presented each year during the Alliance Fall Group Meeting in November. 

Richard Stone, MD, has been named the 2025 recipient of the RLS CALGB Achievement Award. Dr. Stone holds the Lunder Family Chair in Leukemia and serves as Professor of Medicine at Harvard Medical School. He is also the Chief of Staff at Dana-Farber Cancer Institute and Director of the Translational Research Leukemia Division within the Department of Medical Oncology.

For more information about this award, please reach out to Awards@AllianceNCTN.org.

Recent recipient includes: 

>> 2024: Richard M. Goldberg, MD, Professor Emeritus, West Virginia University Cancer Institute
>> 2023: Jeffrey Crawford, MD, Clinical Director, Duke Cancer Institute
>> 2021: M. Margaret (Peggy) Kemeny, MD, FACS, Director, Queens Hospital Center